Flachenecker, P <br/><br/>
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Oct 2001 
 - 327-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1177/135245850100700509  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Autonomic Nervous System Diseases--etiology<br/>Catecholamines--blood<br/>Cross-Sectional Studies<br/>Disability Evaluation<br/>Disease Progression<br/>Female<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--complications<br/>Parasympathetic Nervous System--physiopathology<br/>Recurrence<br/>Sympathetic Nervous System--physiopathology<br/>Vagus Nerve--physiopathology